VivoPower International PLC Provides Notification on Regaining Compliance with Minimum Bid Price Rule
LONDON, June 19, 2020 (GLOBE NEWSWIRE) —On June 17, 2020, VivoPower International PLC (Nasdaq: VVPR) (the “Company”) received a letter […]
Aesthetic Medical International Holdings Group Limited to Host First Quarter 2020 Earnings Conference Call at 8:00 am ET on June 26, 2020
Shenzhen, China, June 19, 2020 (GLOBE NEWSWIRE) — Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a […]
WW to Present at Jefferies Virtual Consumer Conference
NEW YORK, June 19, 2020 (GLOBE NEWSWIRE) — WW International, Inc. (Nasdaq: WW), a global wellness company powered by the […]
Envision Pain Management Selects MTBC’s CareCloud to Support Operational Growth
SOMERSET, N.J., June 19, 2020 (GLOBE NEWSWIRE) — MTBC, Inc. (Nasdaq: MTBC) (Nasdaq: MTBCP), a leading provider of cloud-based healthcare […]
Genetron Health Announces Pricing of Initial Public Offering
BEIJING, China, June 19, 2020 (GLOBE NEWSWIRE) — Genetron Holdings Limited (“Genetron Health” or the “Company”), a China-based precision oncology […]
Veru Enrolls First Patient in Phase 2 Clinical Trial of Novel Drug, VERU-111, to Combat COVID-19
MIAMI, June 19, 2020 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company with a focus […]
MyoKardia Announces Danicamtiv Data Presentation at the European Society of Cardiology’s Virtual Heart Failure Association Discoveries
— MyoKardia to Host Conference Call at 8:30 a.m. ET on Monday, June 22, 2020 —BRISBANE, Calif., June 19, 2020 […]
Retrophin to Present at the BMO 2020 Prescriptions for Success Healthcare Conference
SAN DIEGO, June 19, 2020 (GLOBE NEWSWIRE) — Retrophin, Inc. (NASDAQ: RTRX) today announced that Eric Dube, Ph.D., chief executive […]
Ovid Therapeutics Receives FDA Rare Pediatric Disease Designation for OV101 for the Treatment of Angelman Syndrome
NEW YORK, June 19, 2020 (GLOBE NEWSWIRE) — Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that […]
CymaBay Therapeutics Presents Data at Digestive Disease Week 2020 Online Education
Data from previously completed open-label phase 2 study supports potential for seladelpar to improve pruritus (itching) in patients with PBCImprovements […]
